Patterns in the Reporting of Aggressive Histologic Subtypes in Papillary Thyroid Cancer
View abstract on PubMed
Summary
This summary is machine-generated.Aggressive papillary thyroid cancer (PTC) subtypes are linked to poorer outcomes. Reporting varies by facility type and region, suggesting potential geographic or diagnostic factors influencing diagnosis.
Area Of Science
- Oncology
- Pathology
- Epidemiology
Background
- Papillary thyroid cancer (PTC) has aggressive subtypes like tall cell, columnar, and diffuse sclerosing.
- These aggressive subtypes (aPTC) are increasing in incidence but show wide reporting variations.
- Understanding reporting factors and outcomes for aPTC compared to classic PTC (cPTC) is crucial.
Purpose Of The Study
- To identify and compare factors associated with reporting aggressive PTC subtypes (aPTC) versus classic PTC (cPTC).
- To secondarily investigate differences in patient outcomes between aPTC and cPTC.
Main Methods
- Utilized the National Cancer Database (2004-2017) to identify cPTC and aPTC cases.
- Analyzed patient demographics, facility characteristics, and clinicopathologic variables.
- Performed survival analysis to compare outcomes and identified predictors of aPTC reporting.
Main Results
- Academic facilities were more likely to report aPTC than other facility types (1.4-2.0 times).
- The Middle Atlantic region reported more aPTC cases compared to other regions, despite regional variations in total facility numbers.
- Aggressive PTC subtypes demonstrated higher rates of aggressive features and worse 5-year overall survival (90.5%) compared to classic PTC (94.5%).
Conclusions
- Aggressive PTC subtypes are associated with significantly worse patient outcomes.
- Reporting of aPTC is more prevalent in academic facilities and the Middle Atlantic region.
- Findings suggest a need to explore environmental/geographic factors and improve diagnostic awareness for aPTC.

